Arrhythmias & electrophysiology

Volume–outcome analysis of in-hospital complications after cardiac implantable electronic device implantation: a 250 000-case study

Eur Heart J Qual Care Clin OutcomesPublished Volume-outcome analysis

Authors' conclusion

This study demonstrates a statistically significant association between implantation volume and complication rates across all CIED procedures, with the effect being particularly pronounced among pacemaker patients.

Study context

Population
All first inpatient cardiac implantable electronic device (CIED) implantations performed between 1 January 2010 and 31 December 2020, in hospitals across North Rhine-Westphalia
Participants
249,118 cases
Comparison
Hospital implantation volume and complication rates
Outcome
Overall complication rate
Methodological detailsflexible generalized additive mixed model, mandatory quality assurance data
  • Flexible generalized additive mixed model
  • Mandatory quality assurance data

Main finding

As reported in the abstract

Overall complication rate

2.4%

Lead-related issues (most common)

1.5%

Further findings

Predictors of complications

Strongest predictors: American Society of Anaesthesiologists Class 4-5, New York Heart Association Class IV, subclavian vein access, and dual-chamber pacemaker systems
  • Forest plot analysis

Association between implantation volume and complications

Significant association, particularly among pacemaker patients
P < 0.001
Area under the curve (AUC)
0.7
Relevant reduction in hospital stays and healthcare costs

Modelled 50-case annual cut-off

Complications prevented
∼16%
Patients redirected to other hospitals
∼16%
  • Modelling

Original publication

Volume–outcome analysis of in-hospital complications after cardiac implantable electronic device implantation: a 250 000-case study. Eur Heart J Qual Care Clin Outcomes. Published 17 August 2026. doi:10.1093/ehjqcco/qcag109

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.